David La

976 total citations
30 papers, 713 citations indexed

About

David La is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, David La has authored 30 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in David La's work include Carcinogens and Genotoxicity Assessment (11 papers), DNA Repair Mechanisms (5 papers) and Mast cells and histamine (3 papers). David La is often cited by papers focused on Carcinogens and Genotoxicity Assessment (11 papers), DNA Repair Mechanisms (5 papers) and Mast cells and histamine (3 papers). David La collaborates with scholars based in United States, Canada and Belgium. David La's co-authors include James A. Swenberg, Jun Nakamura, John R. Froines, Patricia B. Upton, Kuen‐Yuh Wu, Robin L. Thurmond, Paul J. Dunford, Sandra S. Snook, Satoshi Yamaguchi and Pao-Hwa Lin and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

David La

29 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David La United States 15 309 251 150 106 53 30 713
Kousuke Ishino Japan 16 272 0.9× 137 0.5× 61 0.4× 85 0.8× 40 0.8× 32 676
Caitlin Harris United States 10 485 1.6× 363 1.4× 212 1.4× 141 1.3× 104 2.0× 15 1.1k
Marwa Hassan Egypt 16 317 1.0× 176 0.7× 81 0.5× 46 0.4× 40 0.8× 55 806
Josef Strasser United States 8 228 0.7× 236 0.9× 153 1.0× 38 0.4× 43 0.8× 10 700
David C. McMillan United States 19 157 0.5× 104 0.4× 88 0.6× 71 0.7× 95 1.8× 28 732
Alessandra Verdina Italy 17 315 1.0× 293 1.2× 219 1.5× 52 0.5× 25 0.5× 42 815
C. Melción France 16 245 0.8× 214 0.9× 92 0.6× 80 0.8× 18 0.3× 26 736
Gary H. Strauss United States 14 472 1.5× 545 2.2× 234 1.6× 78 0.7× 24 0.5× 24 1.0k
Jonathan E. Cox United States 10 153 0.5× 149 0.6× 123 0.8× 39 0.4× 69 1.3× 12 541
Victor Oreffo United Kingdom 17 335 1.1× 172 0.7× 68 0.5× 32 0.3× 45 0.8× 33 797

Countries citing papers authored by David La

Since Specialization
Citations

This map shows the geographic impact of David La's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David La with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David La more than expected).

Fields of papers citing papers by David La

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David La. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David La. The network helps show where David La may publish in the future.

Co-authorship network of co-authors of David La

This figure shows the co-authorship network connecting the top 25 collaborators of David La. A scholar is included among the top collaborators of David La based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David La. David La is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thurmond, Robin L., Bin Chen, Paul J. Dunford, et al.. (2017). Pharmacology and Clinical Activity of Toreforant, a Histamine H 4 Receptor Antagonist. 2(1). 4 indexed citations
2.
Thurmond, Robin L., Jennifer D. Venable, Brad M. Savall, et al.. (2017). Clinical Development of Histamine H4 Receptor Antagonists. Handbook of experimental pharmacology. 241. 301–320. 36 indexed citations
3.
Jing, Ying, et al.. (2017). An Immunohistochemical Investigation of Renal Phospholipidosis and Toxicity in Rats. International Journal of Toxicology. 36(5). 386–394. 6 indexed citations
4.
Ji, Hezhao, Robert Kozak, Mia J. Biondi, et al.. (2015). Next generation sequencing of the hepatitis C virus NS5B gene reveals potential novel S282 drug resistance mutations. Virology. 477. 1–9. 32 indexed citations
5.
Thurmond, Robin L., Bin Chen, Paul J. Dunford, et al.. (2014). Clinical and Preclinical Characterization of the Histamine H4 Receptor Antagonist JNJ-39758979. Journal of Pharmacology and Experimental Therapeutics. 349(2). 176–184. 48 indexed citations
6.
Ward, Peter & David La. (2014). Testicular distribution and toxicity of a novel LTA4H inhibitor in rats. Toxicology and Applied Pharmacology. 278(1). 26–30. 5 indexed citations
7.
La, David, Hani El‐Gabalawy, Anand Kumar, et al.. (2011). Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study. PLoS ONE. 6(12). e29200–e29200. 28 indexed citations
8.
La, David, et al.. (2002). Analysis of DNA adducts in rats exposed to pentachlorophenol. Carcinogenesis. 23(2). 365–369. 31 indexed citations
9.
Salganik, R. I., Anna Dikalova, Sergey Dikalov, et al.. (2001). Antioxidants Selectively Protecting Neurochemical Functions in Rats Overproducing Reactive Oxygen Species. 4(1). 49–54. 4 indexed citations
11.
Lin, Pao-Hwa, Jun Nakamura, Satoshi Yamaguchi, et al.. (2001). Oxidative damage and direct adducts in calf thymus DNA induced by the pentachlorophenol metabolites, tetrachlorohydroquinone and tetrachloro-1,4-benzoquinone. Carcinogenesis. 22(4). 627–634. 41 indexed citations
12.
Nakamura, Jun, David La, & James A. Swenberg. (2000). 5′-Nicked Apurinic/Apyrimidinic Sites Are Resistant to β-Elimination by β-Polymerase and Are Persistent in Human Cultured Cells after Oxidative Stress. Journal of Biological Chemistry. 275(8). 5323–5328. 92 indexed citations
13.
La, David & James A. Swenberg. (1996). DNA adducts: biological markers of exposure and potential applications to risk assessment. Mutation Research/Reviews in Genetic Toxicology. 365(1-3). 129–146. 108 indexed citations
14.
Wilson, Patrick M., David La, & John R. Froines. (1996). Hemoglobin and DNA adduct formation in Fischer-344 rats exposed to 2,4- and 2,6-toluene diamine. Archives of Toxicology. 70(10). 591–598. 7 indexed citations
15.
La, David, et al.. (1996). The Effects of Exposure Route on DNA Adduct Formation and Cellular Proliferation by 1,2,3-Trichloropropane. Toxicology and Applied Pharmacology. 140(1). 108–114. 12 indexed citations
16.
La, David, et al.. (1995). DNA adduct formation in B6C3F1 mice and Fischer-344 rats exposed to 1, 2, 3-trichloropropane. Carcinogenesis. 16(6). 1419–1474. 8 indexed citations
17.
La, David, et al.. (1995). Dose-response relationships for carcinogens. Toxicology Letters. 82-83. 751–756. 52 indexed citations
18.
La, David & John R. Froines. (1994). Formation and removal of DNA adducts in Fischer-344 rats exposed to 2,4-diaminotoluene. Archives of Toxicology. 69(1). 8–13. 7 indexed citations
19.
La, David & John R. Froines. (1993). Comparison of DNA binding between the carcinogen 2,6-dinitrotoluene and its noncarcinogenic analog 2,6-diaminotoluene. Mutation Research Letters. 301(2). 79–85. 16 indexed citations
20.
La, David & John R. Froines. (1992). 32P-postlabelling analysis of DNA adducts from Fischer-344 rats administered 2,4-diaminotoluene. Chemico-Biological Interactions. 83(2). 121–134. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026